Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
JSKN-003 by Alphamab Oncology for Ovarian Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Bladder Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Breast Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Lung Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Lung Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Head And Neck Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Head And Neck Cancer. According to...
JSKN-003 by Alphamab Oncology for Gastric Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Esophageal Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase...